Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Charles Chuah & Junia V Melo. (2009) Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib. OncoTargets and Therapy 2, pages 83-94.
Read now
Read now
Mike G. Martin, John F. Dipersio & Geoffrey L. Uy. (2009) Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia & Lymphoma 50:1, pages 14-23.
Read now
Read now
Seong-Wook Yun, Alexa Ertmer, Eckhard Flechsig, Sabine Gilch, Peter Riederer, Manfred Gerlach, Hermann M Schätzl & Michael A Klein. (2007) The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery. Journal of Neurovirology 13:4, pages 328-337.
Read now
Read now
Articles from other publishers (34)
Mhairi Copland. (2022) Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity. British Journal of Haematology 199:5, pages 665-678.
Crossref
Crossref
Patrick A. BrownBijal ShahAnjali AdvaniPatricia AounMichael W. BoyerPatrick W. BurkeDaniel J. DeAngeloShira DinnerAmir T. FathiJordan GauthierNitin JainSuzanne KirbyMichaela LiedtkeMark LitzowAaron LoganSelina LugerLori J. ManessStephanie MassaroRyan J. MattisonWilliam MayOlalekan OluwoleJae ParkAmanda PrzespolewskiSravanti RangarajuJeffrey E. RubnitzGeoffrey L. UyMadhuri VusirikalaMatthew Wieduwilt, Beth LynnRyan A. BerardiDeborah A. Freedman-CassMallory Campbell. (2021) Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 19:9, pages 1079-1109.
Crossref
Crossref
Marcus A. Healey, Daniel J. Allendorf, Uma Borate & Ankit Madan. (2021) CNS Involvement in a Patient with Chronic Myeloid Leukemia. Case Reports in Hematology 2021, pages 1-5.
Crossref
Crossref
Ali H. Palejwala, Kyle P. O'Connor, Helen Shi, Lance Villeneuve, Teresa Scordino & Chad A. Glenn. (2019) Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report. Journal of Clinical Neuroscience 64, pages 269-276.
Crossref
Crossref
Shilpa Paul, Hagop Kantarjian & Elias J. Jabbour. (2016) Adult Acute Lymphoblastic Leukemia. Mayo Clinic Proceedings 91:11, pages 1645-1666.
Crossref
Crossref
Magdalena Czader & Attilio Orazi. (2015) Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms. American Journal of Clinical Pathology 144:2, pages 188-206.
Crossref
Crossref
SHIUE-WEI LAI, TZU-CHUAN HUANG, JIA-HONG CHEN, YI-YING WU & PING-YING CHANG. (2015) Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report. Oncology Letters 9:4, pages 1957-1961.
Crossref
Crossref
Rohit Gulati, Yaser Alkhatib, Vijayalakshmi Donthireddy, Michelle Madden Felicella, Madhu P. Menon & Kedar V. Inamdar. (2015) Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature. Case Reports in Pathology 2015, pages 1-7.
Crossref
Crossref
Mi-Jung Park, Pil-Whan Park, Yiel-Hea Seo, Kyung-Hee Kim, Ja-Young Seo, Ji-Hun Jeong, Moon Jin Kim, Jin-Woo Jeong, Jeong-Yeal Ahn & Jinny Park. (2014) A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib. Annals of Laboratory Medicine 34:3, pages 247-251.
Crossref
Crossref
Pia Raanani. (2013) Taming of the Shrew - Overcoming Extramedullary Blast Crisis in the Era of the New Tyrosine Kinase Inhibitors. Acta Haematologica 130:2, pages 108-110.
Crossref
Crossref
Mitsutaka Nishimoto, Hirohisa Nakamae, Ki-Ryang Koh, Saori Kosaka, Kana Matsumoto, Kunihiko Morita, Hideo Koh, Takahiko Nakane, Masahiko Ohsawa & Masayuki Hino. (2013) Dasatinib Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation for an Isolated Central Nervous System Blast Crisis in Chronic Myelogenous Leukemia. Acta Haematologica 130:2, pages 111-114.
Crossref
Crossref
Philippe Rousselot & André Delannoy. (2011) Optimal Pharmacotherapeutic Management of Acute Lymphoblastic Leukaemia in the Elderly. Drugs & Aging 28:9, pages 749-764.
Crossref
Crossref
Massimo Breccia, Michelina Santopietro, Laura Cannella, Vincenzo Federico, Giuseppina Loglisci, Alessandra Serrao, Luigi Petrucci, Adriano Salaroli, Mauro Nanni, Maria Stefania De Propris, Daniela Diverio & Giuliana Alimena. (2011) Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib. Leukemia Research 35:6, pages e91-e92.
Crossref
Crossref
Robert P. Hasserjian. (2011) Chronic myelogenous leukemia in the age of imatinib: assessing response, acceleration, and blast phase. Journal of Hematopathology 4:2, pages 81-92.
Crossref
Crossref
Paul M. Barr, Richard J. Creger & Nathan A. Berger. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
127
144
.
Peter Valent. (2010) Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?. European Journal of Clinical Investigation 40:10, pages 918-931.
Crossref
Crossref
D. Focosi & R. E. Kast. (2010) Improving imatinib delivery to central nervous system. Internal Medicine Journal 40:4, pages 318-319.
Crossref
Crossref
Anish Thomas, Constance K. Stein, Teresa C. Gentile & Chirag M. Shah. (2010) Isolated CNS relapse of CML after bone marrow transplantation. Leukemia Research 34:4, pages e113-e114.
Crossref
Crossref
Peter Valent. (2010) Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives. Clinical Medicine Insights: Therapeutics 2, pages CMT.S2439.
Crossref
Crossref
Philippe Aftimos & Fady Nasr. (2009) Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: Case report and review of the literature. Leukemia Research 33:11, pages e178-e180.
Crossref
Crossref
Y. Isobe, K. Sugimoto, A. Masuda, Y. Hamano & K. Oshimi. (2009) Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate. Internal Medicine Journal 39:6, pages 408-411.
Crossref
Crossref
Oliver G. Ottmann & Heike Pfeifer. (2009) Management of Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). Hematology 2009:1, pages 371-381.
Crossref
Crossref
Peter Valent, Thomas Lion, Dominik Wolf, Christian Sillaber, Hermine Agis, Andreas Petzer, Alois Lang, Peter Kalhs, Dietmar Geissler, Richard Greil, Werner Linkesch, Sonja Burgstaller, Josef Thaler & Günther Gastl. (2008) Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformDiagnostische Algorithmen, Prognose und Therapie in der Chronisch Myeloischen Leukämie (CML): Ein Proposal der Österreichischen CML-Plattform. Wiener klinische Wochenschrift 120:21-22, pages 697-709.
Crossref
Crossref
Arturo Vega-Ruiz, Susan O?Brien, Jorge Cortes, Partow Kebriaei, Deborah Thomas, Hagop Kantarjian & Farhad Ravandi. (2008) Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate. Leukemia Research 32:9, pages 1468-1471.
Crossref
Crossref
Kimmo Porkka, Perttu Koskenvesa, Tuija LundánJohanna RimpiläinenSatu Mustjoki, Richard SmyklaRobert WildRoger LuoMontserrat ArnanBenoit BrethonLydia EccersleyHenrik Hjorth-HansenMartin HöglundHana KlamovaHåvar KnutsenSuhag ParikhEmmanuel RaffouxFranz GruberFinella Brito-BabapulleHervé DombretRafael F. DuarteErkki Elonen, Ron PaquetteC. Michel Zwaan & Francis Y. F. Lee. (2008) Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia. Blood 112:4, pages 1005-1012.
Crossref
Crossref
K. J. Aichberger, S. Herndlhofer, H. Agis, W. R. Sperr, H. Esterbauer, W. Rabitsch, P. Knöbl, O. A. Haas, R. Thalhammer, I. Schwarzinger, C. Sillaber, U. Jäger & P. Valent. (2007) Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy. European Journal of Clinical Investigation 37:10, pages 808-813.
Crossref
Crossref
Asumi YokotaShinya KimuraSatohiro MasudaEishi AshiharaJunya KurodaKiyoshi SatoYuri KamitsujiEri KawataYasuyuki DeguchiYoshimasa UrasakiYasuhito TeruiMartin Ruthardt, Takanori UedaKiyohiko HatakeKen-ichi InuiTaira Maekawa. (2006) INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity. Blood 109:1, pages 306-314.
Crossref
Crossref
P. Raanani, O. Shpilberg & I. Ben-Bassat. (2007) Extramedullary disease and targeted therapies for hematological malignancies—is the association real?. Annals of Oncology 18:1, pages 7-12.
Crossref
Crossref
James M.G. Larkin & Tim Eisen. (2006) Kinase inhibitors in the treatment of renal cell carcinoma. Critical Reviews in Oncology/Hematology 60:3, pages 216-226.
Crossref
Crossref
B?rbara Mel?ndez, Concepci?n Fia?o, Yolanda Ruano, Jose L. Hern?ndez-Moneo, Manuela Mollejo & Pedro Martinez. (2006) BCR gene disruption in a pilomyxoid astrocytoma. Neuropathology 26:5, pages 442-446.
Crossref
Crossref
Hyun Jung Kim, Chul Won Jung, Kihyun Kim, Jin Seok Ahn, Won Seog Kim, Kwan Park, Young Hye Ko, Won Ki Kang & Keunchil Park. (2006) Isolated Blast Crisis in CNS in a Patient With Chronic Myelogenous Leukemia Maintaining Major Cytogenetic Response After Imatinib. Journal of Clinical Oncology 24:24, pages 4028-4029.
Crossref
Crossref
Merat Karbasian Esfahani, Evelyn L. Morris, Janice P. Dutcher & Peter H. Wiernik. (2006) Blastic phase of chronic myelogenous leukemia. Current Treatment Options in Oncology 7:3, pages 189-199.
Crossref
Crossref
Mitsuhiro Matsuda, Yasuyoshi Morita, Takahiro Shimada, Junichi Miyatake, Chikara Hirase, Miyako Tanaka, Yoichi Tatsumi, Yasuhiro Maeda & Akihisa Kanamaru. (2005) Extramedullary Blast Crisis Derived from 2 Different Clones in the Central Nervous System and Neck during Complete Cytogenetic Remission of Chronic Myelogenous Leukemia Treated with Imatinib Mesylate. International Journal of Hematology 81:4, pages 307-309.
Crossref
Crossref
Yavuz Beyazit, Salih Aksu, Murat Kekilli, Ibrahim C. Haznedaroglu, Sadettin Kilickap & Hakan Goker. (2005) Unusual extramedullary relapses under imatinib mesylate treatment in chronic myeloid leukemia. American Journal of Hematology 79:1, pages 79-80.
Crossref
Crossref